Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-27 @ 9:05 AM
Study NCT ID:
NCT01126034
Status:
COMPLETED
Last Update Posted:
2015-12-04
First Post:
2010-05-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
Sponsor:
University of Pennsylvania
Organization:
Study Overview
Official Title:
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators hypothesized that:
1\) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.
1\) an intervention targeted at the prescribing physician would increase the rate of a metoclopramide discontinuation among patients prescribed the medication for questionable or unclear indications; and 2) the discontinuation would be durable.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: